BackAdaptimmune Therapeutics Plc Overview

Adaptimmune Therapeutics Plc Operating Income

Operating Income for ADAP.

Quarterly Operating Income

$-30288000.00
↓ 145.61% YoY

As of Jun 30, 2025

Annual Operating Income (TTM)

$-164220000.00
↑ 97.47% YoY

Trailing 12 months ending Jun 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin